Skip to main content

Milestone 1.G

Augment current and future human cohorts with more advanced, longitudinal immunological profiling (e.g. Cytof) to enable precision medicine research and to better understand the roles of the different arms of the central nervous system and peripheral immunity in brain aging and AD.


Success Criteria

  • Provide supplemental funding to support longitudinal immunologic profiling to existing and newly launched mid-life and aging cohorts with rich-phenotypic data on brain health.


Research Implementation Area
Population Studies and Precision Medicine
Timeline
2018–2024
Status
To Be Initiated

Relevant Recommendations